Abstract
The generation of an antigen-specific T-lymphocyte response is a complex multi-step process. Upon T-cell receptor-mediated recognition of antigen presented by activated dendritic cells, naive T-lymphocytes enter a program of proliferation and differentiation, during the course of which they acquire effector functions and may ultimately become memory T-cells. A major goal of modern immunology is to precisely identify and characterize effector and memory T-cell subpopulations that may be most efficient in disease protection. Sensitive methods are required to address these questions in exceedingly low numbers of antigen-specific lymphocytes recovered from clinical samples, and not manipulated in vitro. We have developed new techniques to dissect immune responses against viral or tumor antigens. These allow the isolation of various subsets of antigen-specific T-cells (with major histocompatibility complex [MHC]-peptide multimers and five-color FACS sorting) and the monitoring of gene expression in individual cells (by five-cell reverse transcription-polymerase chain reaction [RT-PCR]). We can also follow their proliferative life history by flow-fluorescence in situ hybridization (FISH) analysis of average telomere length. Recently, using these tools, we have identified subpopulations of CD8+ T-lymphocytes with distinct proliferative history and partial effector-like properties. Our data suggest that these subsets descend from recently activated T-cells and are committed to become differentiated effector T-lymphocytes.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Van Der Bruggen, P., Zhang, Y., Chaux, P., et al. (2002) Tumor-specific shared antigenic peptides recognized by human T-cells. Immunol. Rev. 188, 51–64.
Speiser, D., Pittet, M. J., Rimoldi, D., et al. (2003) Evaluation of melanoma vaccines with molecularly defined antigens by ex vivo monitoring of tumor-specific T cells. Seminars in Cancer Biology 13, 461–472.
Dudley, M. E. and Rosenberg, S. A. (2003) Adoptive-cell-transfer therapy for the treatment of patients with cancer. Nat. Rev. Cancer 3, 666–675.
Ho, W. Y., Blattman, J. N., Dossett, M. L., Yee, C., and Greenberg, P. D. (2003) Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destruction. Cancer Cell 3, 431–437.
Waldmann, T. A., Levy, R., and Coller, B. S. (2000) Emerging therapies: spectrum of applications of monoclonal antibody therapy. Hematology (Am. Soc. Hematol. Educ. Program) 2000 394–408.
Marchand, M., Punt, C. J., Aamdal, S., et al. (2003) Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SB AS-2: a clinical report. Eur. J. Cancer 39, 70–77.
Scanlan, M. J., Gure, A. O., Jungbluth, A. A., Old, L. J., and Chen, Y. T. (2002) Cancer/ testis antigens: an expanding family of targets for cancer immunotherapy. Immunol. Rev. 188, 22–32.
Rosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., et al. (2003) Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanoma. Clin. Cancer Res. 9, 2973–2980.
Smith, J. W., 2nd, Walker, E. B., Fox, B. A., et al. (2003) Adjuvant immunization of HLAA2 positive melanoma patients with a modified gp100 peptide induces peptide-specific CD8+T-cell responses. J. Clin. Oncol. 21, 1562–1573.
Romero, P., Valmori, D., Pittet, M. J., et al. (2002) Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma. Immunol. Rev. 188, 81–96.
Ghanekar, S. A. and Maecker, H. T. (2003) Cytokine flow cytometry: multiparametric approach to immune function analysis. Cytotherapy 5, 1–6.
Pittet, M. J., Zippelius, A., Speiser, D. E., et al. (2001) Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases. J. Immunol. 166, 7634–7640.
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., et al. (1996) Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94–96.
Kawakami, Y., Eliyahu, S., Sakaguchi, K., et al. (1994) Identification of the immuno dominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med. 180, 347–352.
Pittet, M. J., Zippelius, A., Valmori, D., Speiser, D. E., Cerottini, J. C., and Romero, P. (2002) Melan-A/MART-1-specific CD8 T cells: from thymus to tumor. Trends Immunol. 23, 325–328.
Brady, G. and Iscove, N. N. (1993) Construction of cDNA libraries from single cells. Methods Enzymol. 225, 611–623.
Sauvageau, G., Lansdorp, P. M., Eaves, C. J., et al. (1994) Differential expression of homeobox genes in functionally distinct CD34+subpopulations of human bone marrow cells. Proc. Natl. Acad. Sci. USA 91, 12,223–12,227.
Bigouret, V., Hoffmann, T., Arlettaz, L., et al. (2003) Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cyto toxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors. Blood 101, 3198–3204.
Rufer, N., Zippelius, A., Batard, P., et al. (2003) Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions. Blood 102, 1779–1787.
Rufer, N., Dragowska, W., Thornbury, G., Roosnek, E., and Lansdorp, P. M. (1998) Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat. Biotechnol. 16, 743–747.
Rufer, N., Brummendorf, T. H., Kolvraa, S., et al. (1999) Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J. Exp. Med. 190, 157–167.
Zippelius, A., Pittet, M. J., Batard, P., et al. (2002) Thymic selection generates a large T cell pool recognizing a self-peptide in humans. J. Exp. Med. 195, 485–494.
Papagno, L., Spina, C. A., Marchant, A., et al. (2004) Immune activation and CD8+T-cell differentiation towards senescence in HIV-1 infection. PLoS 2(2), e20.
Levsky, J. M., Shenoy, S. M., Pezo, R. C., and Singer, R. H. (2002) Single-cell gene expression profiling. Science 297, 836–840.
Hultdin, M., Gronlund, E., Norrback, K., Eriksson-Lindstrom, E., Just, T., and Roos, G. (1998) Telomere analysis by fluorescence in situ hybridization and flow cytometry. Nucleic Acids Res. 26, 3651–3656.
Lauzon, W., Sanchez Dardon, J., Cameron, D. W., and Badley, A. D. (2000) Flow cytometric measurement of telomere length. Cytometry 42, 159–164.
Baerlocher, G. M., Mak, J., Tien, T., and Lansdorp, P. M. (2002) Telomere length mea-surement by fluorescence in situ hybridization and flow cytometry: tips and pitfalls. Cytometry 47, 89–99.
Harley, C. B., Futcher, A. B., and Greider, C. W. (1990) Telomeres shorten during ageing of human fibroblasts. Nature 345, 458–460.
Allsopp, R. C., Vaziri, H., Patterson, C., et al. (1992) Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. USA 89, 10,114–10,118.
Lansdorp, P. M., Poon, S., Chavez, E., et al. (1997) Telomeres in the haemopoietic system. Ciba Found. Symp. 211, 209–218; discussion 19-22.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc.
About this protocol
Cite this protocol
Rufer, N., Reichenbach, P., Romero, P. (2005). Methods for the Ex Vivo Characterization of Human CD8+T Subsets Based on Gene Expression and Replicative History Analysis. In: Ludewig, B., Hoffmann, M.W. (eds) Adoptive Immunotherapy: Methods and Protocols. Methods in Molecular Medicine™, vol 109. Humana Press. https://doi.org/10.1385/1-59259-862-5:265
Download citation
DOI: https://doi.org/10.1385/1-59259-862-5:265
Publisher Name: Humana Press
Print ISBN: 978-1-58829-406-7
Online ISBN: 978-1-59259-862-5
eBook Packages: Springer Protocols